ArteraAI vs Navina
A side-by-side comparison built from both listings. Blank cells mean the company has not given that detail; we never guess.
ArteraAI compared with Navina
| Detail | 
ArteraAI | 
Navina |
|---|
| What it does | Personalized precision medicine powered by AI for cancer therapy
| AI copilot for value-based care that helps clinicians improve HCC accuracy, close care gaps, and reduce documentation burden
|
|---|
| Stage | Not given
| Established
|
|---|
| Founded | Not given
| 2019
|
|---|
| Based in | US
| US
|
|---|
| Pricing model | Contact for pricing
| Contact for pricing
|
|---|
| Pricing | Not given
| Not given
|
|---|
| Key features | - Analyzes digital pathology with no additional tissue staining required
- Rapid results within 1-2 days after specimen receipt
- Validated across diverse populations including African American and non-African American men
- FDA De Novo authorization for prostate cancer risk stratification
- Insurance coverage for Medicare and many commercial plans
- Provides 5 and 10-year distant metastasis risk for breast cancer
- Identifies breast cancer patients who benefit from chemotherapy
- Included in NCCN Clinical Practice Guidelines for Prostate Cancer
| - AI-powered HCC recommendations at the point of care
- Clinical evidence backing for every insight
- Seamless EHR integration
- Ambient transcription and chart review support
- Care gap identification and quality management
- Multi-source data reconciliation
- Analytics and performance tracking
- 600+ AI algorithms
- Clinician-first interface design
|
|---|
| What makes it different | - No additional tissue preparation needed, uses existing H&E slides
- Validated across multiple large randomized phase III clinical trials
- FDA De Novo clearance as Software as a Medical Device
- Financial assistance program to make tests affordable regardless of income
| - Best in KLAS 2025 for Clinician Digital Workflow
- Explainable AI with clinical evidence backing every recommendation
- Seamless EHR integration enabling rapid clinician adoption
|
|---|
| Community votes | 0 | 0 |
|---|
| DR (Domain Rating by Ahrefs) | 57 ● no change since last check | 41 ● no change since last check |
|---|
| Trust Flow (Majestic) | 15 | 17 |
|---|
| Citation Flow (Majestic) | 27 | 36 |
|---|
| Referring domains (Majestic) | 285 | 395 |
|---|
5 details filled in for both companies.
More alternatives to ArteraAI More alternatives to Navina